Interestingly, additional Transwell experiments showed that CCR9/CCL25 promoted the migration and invasiveness of lung cancer stem cells isolated from A549 cells, and the authors suggested that CCR9 or its ligand CCL25 could be used as a therapeutic target for lung adenocarcinoma. The gene discussed is CCR9; the disease is lung carcinoma.